Qyuns Therapeutics (02509) submitted a Next Day Disclosure Return on 19 November 2025, reporting a repurchase of 97,200 H shares on the Stock Exchange on 19 November 2025. Following this transaction, the total issued shares excluding treasury shares stood at 226,289,000, while treasury shares increased to 782,600.

According to the disclosed information, the repurchased shares remain held as treasury shares, and the aggregate consideration for the repurchase was approximately HKD 1,996,206.12. Under the current repurchase mandate, the moratorium period on issuing new shares or disposing of treasury shares will last until 19 December 2025.